BCRX (BioCryst Pharmaceuticals) Inventories, Raw Materials & Components: $0.0 Mil (As of Mar. 2026)


BCRX BioCryst Pharmaceuticals Inc BCRX
64 GF Score
Price $9.97
GF Value $12.75
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is BioCryst Pharmaceuticals Inventories, Raw Materials & Components?

BioCryst Pharmaceuticals BCRX +0.40% 64 Inventories, Raw Materials & Components is $0.0 Mil as of Mar. 2026. GuruFocus rates BCRX with a GF Score™ of 64/100 and a GF Value™ of $12.75 (Modestly Undervalued). The stock has 4 warning signs investors should review.

BioCryst Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $0.0 Mil.

BioCryst Pharmaceuticals's annual raw materials declined from Dec. 2023 ($6.4 Mil) to Dec. 2024 ($0.0 Mil) but then stayed the same from Dec. 2024 ($0.0 Mil) to Dec. 2025 ($0.0 Mil).

BioCryst Pharmaceuticals Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for BioCryst Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCryst Pharmaceuticals Inventories, Raw Materials & Components Chart

BioCryst Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.66 8.91 6.45 0.00 0.00

BioCryst Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.74 7.25 0.00 0.00 0.00
BCRX
64GF Score
BioCryst Pharmaceuticals Inc BCRX
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioCryst Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.0 Mil mean?
BioCryst Pharmaceuticals (BCRX) has a Inventories, Raw Materials & Components of $0.0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on BioCryst Pharmaceuticals and its competitors.
Is BioCryst Pharmaceuticals' Inventories, Raw Materials & Components too high?
BioCryst Pharmaceuticals' current Inventories, Raw Materials & Components is $0.0 Mil. Overall, BioCryst Pharmaceuticals has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioCryst Pharmaceuticals' Inventories, Raw Materials & Components compare to PBH and SUPN?
BioCryst Pharmaceuticals' Inventories, Raw Materials & Components of $0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on BioCryst Pharmaceuticals and its competitors. BioCryst Pharmaceuticals's current Inventories, Raw Materials & Components is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioCryst Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, BioCryst Pharmaceuticals (BCRX) is currently considered Modestly Undervalued. The stock's GF Value™ is $12.75, compared to a current price of $9.97 — trading 21.8% below its estimated fair value. The current Inventories, Raw Materials & Components is $0.0 Mil. BioCryst Pharmaceuticals' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For BioCryst Pharmaceuticals (BCRX), the current Inventories, Raw Materials & Components is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioCryst Pharmaceuticals (BCRX) Overvalued in 2026?

Based on GuruFocus' analysis, BioCryst Pharmaceuticals stock appears to be undervalued. The current stock price of $9.97 is trading 21.8% below its estimated GF Value™ of $12.75. GuruFocus considers BioCryst Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for BCRX:

  • Inventories, Raw Materials & Components: $0.0 Mil
  • GF Value™: $12.75 vs. price of $9.97 (21.8% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the BCRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioCryst Pharmaceuticals Business Description

Other Exchanges BCRX:MexicoBO1:Germany
Address 4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
64GF Score

Get the complete analysis for BCRX

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.97
Price
$12.75
GF Value